🫀 #Aficamten aprobado en China
Un nuevo tratamiento para pacientes adultos con
👉 HCM obstructiva
👉 NYHA II–III
📎 Más información: dengyuepharma.com
📧 info@dengyuemed.com
#MYQORZO #MiocardiopatíaHipertrófica #HCM #Cardiología #EnfermedadesCardíacas #NYHA #ClaseFuncional #DengYueMedicinasEnHongKong

Orsini Partners with Cytokinetics to Enhance Access to MYQORZO™ for Ongoing Heart Conditions Orsini has been selected as the specialty pharmacy for Cytokinetics's MYQORZO™, enhancing access to treatment for obstructive hypertrophic cardiomyopathy.

Orsini Partners with Cytokinetics to Enhance Access to MYQORZO™ for Ongoing Heart Conditions #USA #Elk_Grove_Village #Orsini #Cytokinetics #MYQORZO

GSK closes on approval of asthma hope depemokimab GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.

#GSK #depemokimab #severeasthma #Exdensur #CRSwNP #respiratory #immunology #inflammation #Nucala #mepolizumab #COPD #rarediseases #SerumLifeScienceEurope #Anktiva #NMIBC #SFLPharma #Aumseqa #NSCLC #Cytokinetics #Myqorzo #hypertrophiccardiomyopathy #Moderna #Mnexspike #COVID19vaccine
zurl.co/l8WfN